Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Michael Camilleri, Houssam Halawi & Ibironke Oduyebo. (2017) Biomarkers as a diagnostic tool for irritable bowel syndrome: where are we?. Expert Review of Gastroenterology & Hepatology 11:4, pages 303-316.
Read now
Read now
Michael Camilleri. (2013) Current and future pharmacological treatments for diarrhea-predominant irritable bowel syndrome. Expert Opinion on Pharmacotherapy 14:9, pages 1151-1160.
Read now
Read now
Articles from other publishers (29)
Vasile Valeriu Lupu, Cristina Mihaela Ghiciuc, Gabriela Stefanescu, Cristina Maria Mihai, Alina Popp, Maria Oana Sasaran, Laura Bozomitu, Iuliana Magdalena Starcea, Anca Adam Raileanu & Ancuta Lupu. (2023) Emerging role of the gut microbiome in post-infectious irritable bowel syndrome: A literature review. World Journal of Gastroenterology 29:21, pages 3241-3256.
Crossref
Crossref
Bénédicte Caron, Subrata Ghosh, Silvio Danese & Laurent Peyrin-Biroulet. (2023) Identifying, Understanding, and Managing Fecal Urgency in Inflammatory Bowel Diseases. Clinical Gastroenterology and Hepatology 21:6, pages 1403-1413.e27.
Crossref
Crossref
Giovanni Di Nardo, Cesare Cremon, Annamaria Staiano, Vincenzo Stanghellini, Osvaldo Borrelli, Caterina Strisciuglio, Claudio Romano, Saverio Mallardo, Elena Scarpato, Giovanni Marasco, Silvia Salvatore, Letizia Zenzeri, Enrico Felici, Licia Pensabene, Simona Sestito, Ruggiero Francavilla, Paolo Quitadamo, Mariella Baldassarre, Valentina Giorgio, Renato Tambucci, Chiara Ziparo, Pasquale Parisi, Maria Raffaella Barbaro & Giovanni Barbara. (2022) Role of inflammation in pediatric irritable bowel syndrome. Neurogastroenterology & Motility 35:3.
Crossref
Crossref
Vivek C. Goodoory, Ashok K. Tuteja, Christopher J. Black & Alexander C. Ford. (2023) Systematic Review and Meta-analysis: Efficacy of Mesalamine in Irritable Bowel Syndrome. Clinical Gastroenterology and Hepatology.
Crossref
Crossref
Valeria Castro Tejera, Lena Öhman, Lars Aabakken, Bengt Fellström, Trygve Hausken, Øistein Hovde, Johann P. Hreinsson, Greger Lindberg, Per Venge, Magnus Simrén & Hans Törnblom. (2022) Randomised clinical trial and meta‐analysis: mesalazine treatment in irritable bowel syndrome—effects on gastrointestinal symptoms and rectal biomarkers of immune activity. Alimentary Pharmacology & Therapeutics 56:6, pages 968-979.
Crossref
Crossref
William L. Hasler, Gintautas Grabauskas, Prashant Singh & Chung Owyang. (2022) Mast cell mediation of visceral sensation and permeability in irritable bowel syndrome. Neurogastroenterology & Motility 34:7.
Crossref
Crossref
Edoardo Savarino, Fabiana Zingone, Brigida Barberio, Giovanni Marasco, Filiz Akyuz, Hale Akpinar, Oana Barboi, Giorgia Bodini, Serhat Bor, Giuseppe Chiarioni, Gheorghe Cristian, Maura Corsetti, Antonio Di Sabatino, Anca Mirela Dimitriu, Vasile Drug, Dan L. Dumitrascu, Alexander C. Ford, Goran Hauser, Radislav Nakov, Nisha Patel, Daniel Pohl, Cătălin Sfarti, Jordi Serra, Magnus Simrén, Alina Suciu, Jan Tack, Murat Toruner, Julian Walters, Cesare Cremon & Giovanni Barbara. (2022) Functional bowel disorders with diarrhoea: Clinical guidelines of the United European Gastroenterology and European Society for Neurogastroenterology and Motility. United European Gastroenterology Journal 10:6, pages 556-584.
Crossref
Crossref
S Kindt, H Louis, H De Schepper, J Arts, P Caenepeel, D De Looze, A Gerkens, T Holvoet, P Latour, T Mahler, F Mokaddem, S Nullens, H Piessevaux, P Poortmans, G Rasschaert, M Surmont, H Vafa, K Van Malderen, T Vanuytsel, F Wuestenberghs & J Tack. (2022) Belgian consensus on irritable bowel syndrome. Acta Gastro Enterologica Belgica 85:2, pages 360-382.
Crossref
Crossref
P. Layer, V. Andresen, H. Allescher, S. C. Bischoff, M. Claßen, S. Elsenbruch, M. Freitag, T. Frieling, M. Gebhard, M. Goebel-Stengel, W. Häuser, G. Holtmann, J. Keller, M. E. Kreis, W. Kruis, J. Langhorst, P. Lynen Jansen, A. Madisch, H. Mönnikes, S. Müller-Lissner, B. Niesler, C. Pehl, D. Pohl, M. Raithel, G. Röhrig-Herzog, M. Schemann, S. Schmiedel, J. Schwille-Kiuntke, M. Storr, J. C. Preiß, T. Andus, S. Buderus, U. Ehlert, M. Engel, A. Enninger, W. Fischbach, A. Gillessen, J. Gschossmann, F. Gundling, S. Haag, U. Helwig, S. Hollerbach, M. Karaus, M. Katschinski, H. Krammer, R. Kuhlbusch-Zicklam, H. Matthes, D. Menge, S. Miehlke, M. C. Posovszky, R. Schaefert, A. Schmidt-Choudhury, O. Schwandner, A. Schweinlin, H. Seidl, A. Stengel, J. Tesarz, I. van der Voort, W. Voderholzer, G. von Boyen, J. von Schönfeld & T. Wedel. (2021) Update S3-Leitlinie Reizdarmsyndrom: Definition, Pathophysiologie, Diagnostik und Therapie. Gemeinsame Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastroenterologie und Motilität (DGNM) – Juni 2021 – AWMF-Registriernummer: 021/016. Zeitschrift für Gastroenterologie 59:12, pages 1323-1415.
Crossref
Crossref
Antonio Berumen, Adam L. Edwinson & Madhusudan Grover. (2021) Post-infection Irritable Bowel Syndrome. Gastroenterology Clinics of North America 50:2, pages 445-461.
Crossref
Crossref
Fen-Ming Zhang, Sha Li, Liang Ding, Sai-Heng Xiang, Hua-Tuo Zhu, Jing-Hua Yu & Guo-Qiang Xu. (2019) Effectiveness of mesalazine to treat irritable bowel syndrome. Medicine 98:28, pages e16297.
Crossref
Crossref
Robin Spiller. (2019) Significance of Postinfectious Irritable Bowel Syndrome?. Gastroenterology 156:1, pages 14-17.
Crossref
Crossref
Giovanni Barbara, Madhusudan Grover, Premysl Bercik, Maura Corsetti, Uday C. Ghoshal, Lena Ohman & Mirjana Rajilić-Stojanović. (2019) Rome Foundation Working Team Report on Post-Infection Irritable Bowel Syndrome. Gastroenterology 156:1, pages 46-58.e7.
Crossref
Crossref
Sakteesh V. Gurunathan & Madhusudan Grover. 2019. Gastrointestinal Diseases and their Associated Infections. Gastrointestinal Diseases and their Associated Infections
85
95
.
Maria Vannucchi & Stefano Evangelista. (2018) Experimental Models of Irritable Bowel Syndrome and the Role of the Enteric Neurotransmission. Journal of Clinical Medicine 7:1, pages 4.
Crossref
Crossref
Longtu Chen, Sheikh J. Ilham & Bin Feng. (2017) Pharmacological Approach for Managing Pain in Irritable Bowel Syndrome: A Review Article. Anesthesiology and Pain Medicine 7:2.
Crossref
Crossref
C. Traini, S. Evangelista, V. Girod, M.S. Faussone-Pellegrini & M.G. Vannucchi. (2016) Changes of excitatory and inhibitory neurotransmitters in the colon of rats underwent to the wrap partial restraint stress. Neurogastroenterology & Motility 28:8, pages 1172-1185.
Crossref
Crossref
R. Carmona-Sánchez, M.E. Icaza-Chávez, M.V. Bielsa-Fernández, O. Gómez-Escudero, F. Bosques-Padilla, E. Coss-Adame, F. Esquivel-Ayanegui, Á.R. Flores-Rendón, M.A. González-Martínez, F. Huerta-Iga, A. López-Colombo, T.H. Méndez-Gutiérrez, A. Noble-Lugo, J.R. Nogueira-de Rojas, R.H. Raña-Garibay, J.M. Remes-Troche, F. Roesch-Dietlen, M.J. Schmulson, J.C. Soto-Pérez, J.L. Tamayo, L.F. Uscanga, M.Á. Valdovinos, J. Valerio-Ureña & M.R. Zavala-Solares. (2016) The Mexican consensus on irritable bowel syndrome. Revista de Gastroenterología de México (English Edition) 81:3, pages 149-167.
Crossref
Crossref
R. Carmona-Sánchez, M.E. Icaza-Chávez, M.V. Bielsa-Fernández, O. Gómez-Escudero, F. Bosques-Padilla, E. Coss-Adame, F. Esquivel-Ayanegui, Á.R. Flores-Rendón, M.A. González-Martínez, F. Huerta-Iga, A. López-Colombo, T.H. Méndez-Gutiérrez, A. Noble-Lugo, J.R. Nogueira-de Rojas, R.H. Raña-Garibay, J.M. Remes-Troche, F. Roesch-Dietlen, M.J. Schmulson, J.C. Soto-Pérez, J.L. Tamayo, L.F. Uscanga, M.Á. Valdovinos, J. Valerio-Ureña & M.R. Zavala-Solares. (2016) Consenso mexicano sobre el síndrome de intestino irritable. Revista de Gastroenterología de México 81:3, pages 149-167.
Crossref
Crossref
Michael Camilleri, Lionel Buéno, Viola Andresen, Fabrizio De Ponti, Myung-Gyu Choi & Anthony Lembo. (2016) Pharmacologic, Pharmacokinetic, and Pharmacogenomic Aspects of Functional Gastrointestinal Disorders. Gastroenterology 150:6, pages 1319-1331.e20.
Crossref
Crossref
Ching Lam, Wei Tan, Matthew Leighton, Margaret Hastings, Melanie Lingaya, Yirga Falcone, Xiaoying Zhou, Luting Xu, Peter Whorwell, Andrew F Walls, Abed Zaitoun, Alan Montgomery & Robin Spiller. (2016) A mechanistic multicentre, parallel group, randomised placebo-controlled trial of mesalazine for the treatment of IBS with diarrhoea (IBS-D). Gut 65:1, pages 91-99.
Crossref
Crossref
Emma Torbicki, Justin Oh, Sharmistha Mishra, Andrea V. Page & Andrea K. Boggild. (2015) Interventions for post-infectious irritable bowel syndrome: a systematic review of treatment efficacy. Tropical Diseases, Travel Medicine and Vaccines 1:1.
Crossref
Crossref
Z. Mujagic, D. Keszthelyi, Q. Aziz, W. Reinisch, E. G. Quetglas, F. De Leonardis, M. Segerdahl & A. A. M. Masclee. (2015) Systematic review: instruments to assess abdominal pain in irritable bowel syndrome. Alimentary Pharmacology & Therapeutics 42:9, pages 1064-1081.
Crossref
Crossref
Ching Lam, Wei Tan, Matthew Leighton, Margaret Hastings, Melanie Lingaya, Yirga Falcone, Xiaoying Zhou, Luting Xu, Peter Whorwell, Andrew F Walls, Abed Zaitoun, Alan Montgomery & Robin C Spiller. (2015) Efficacy and mode of action of mesalazine in the treatment of diarrhoea-predominant irritable bowel syndrome (IBS-D): a multicentre, parallel-group, randomised placebo-controlled trial. Efficacy and Mechanism Evaluation 2:2, pages 1-62.
Crossref
Crossref
J.-H. La & G. F. Gebhart. (2014) Condition-specific role of colonic inflammatory molecules in persistent functional colorectal hypersensitivity in the mouse. Neurogastroenterology & Motility 26:12, pages 1730-1742.
Crossref
Crossref
Jose L. Barboza, Nicholas J. Talley & Baharak Moshiree. (2014) Current and Emerging Pharmacotherapeutic Options for Irritable Bowel Syndrome. Drugs 74:16, pages 1849-1870.
Crossref
Crossref
Tim Vanuytsel, Jan F. Tack & Guy E. Boeckxstaens. (2014) Treatment of abdominal pain in irritable bowel syndrome. Journal of Gastroenterology 49:8, pages 1193-1205.
Crossref
Crossref
Yehuda Ringel & Nitsan Maharshak. (2013) Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome. American Journal of Physiology-Gastrointestinal and Liver Physiology 305:8, pages G529-G541.
Crossref
Crossref
Michael Camilleri. (2013) Pharmacological agents currently in clinical trials for disorders in neurogastroenterology. Journal of Clinical Investigation 123:10, pages 4111-4120.
Crossref
Crossref